1. Home
  2. TFIN vs INBX Comparison

TFIN vs INBX Comparison

Compare TFIN & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Triumph Financial Inc.

TFIN

Triumph Financial Inc.

N/A

Current Price

$61.18

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

N/A

Current Price

$84.95

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TFIN
INBX
Founded
1981
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
TFIN
INBX
Price
$61.18
$84.95
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$76.00
★ $266.67
AVG Volume (30 Days)
248.1K
★ 268.9K
Earning Date
10-21-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.22
N/A
EPS
★ 1.19
N/A
Revenue
N/A
★ $1,300,000.00
Revenue This Year
$9.34
N/A
Revenue Next Year
$10.35
N/A
P/E Ratio
$54.54
★ N/A
Revenue Growth
N/A
★ 550.00
52 Week Low
$49.27
$57.30
52 Week High
$83.52
$155.29

Technical Indicators

Market Signals
Indicator
TFIN
INBX
Relative Strength Index (RSI) 42.16 46.09
Support Level $60.14 $71.37
Resistance Level $63.67 $86.61
Average True Range (ATR) 2.07 8.14
MACD 0.08 0.17
Stochastic Oscillator 21.81 51.02

Price Performance

Historical Comparison
TFIN
INBX

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: